Literature DB >> 2598980

Is addition of prazosin beneficial in chronic heart failure refractory to angiotensin converting enzyme inhibition?

K Boman, P Eriksson, L Slunga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2598980     DOI： 10.1007/bf00558517

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

Review 1.  Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1983-11       Impact factor: 24.094

2.  Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.

Authors:  J Kugler; C S Maskin; W Frishman; E H Sonnenblick; T H LeJemtel
Journal:  Am Heart J       Date:  1982-11       Impact factor: 4.749

3.  Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.

Authors:  J Bayliss; M S Norell; R Canepa-Anson; C Reid; P Poole-Wilson; G Sutton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

4.  Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.

Authors:  B M Massie; M Packer; J T Hanlon; D T Combs
Journal:  J Am Coll Cardiol       Date:  1983-08       Impact factor: 24.094
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.